logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

David W Snyder

This inventor holds 3 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1992-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David W Snyder. Retrieved from https://idiyas.com/inventor/david-w-snyder-0qaqsqnk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1992 - 1994)
  • Leesburg, FL (US) (2003)

Company Filing History:

goldMedal2 out of 4,517 
 
Eli Lilly and Company
 patents
where one patent can have more than one assignee

Years Active: 1992-2003

Loading Chart...
3 patents (USPTO):Explore Patents
1. PP14389 - Begonia plant named 'Star of David' (2003-12-17),
2. 5283361 - N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as (1994-02-01),
3. 5130485 - N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas (1992-07-14),

Title: The Innovative Contributions of David W. Snyder

Introduction

David W. Snyder, an accomplished inventor based in Indianapolis, Indiana, holds three significant patents that reflect his diverse expertise in both horticulture and medicinal chemistry. His innovative contributions have made a notable impact in his field, especially while working with Eli Lilly and Company.

Latest Patents

Among his latest patents is the Begonia plant named 'Star of David'. This cultivar of Begonia rex is distinguished by its juvenile flowers, featuring a remarkable mutation with large clusters of forty flowers. The 'Star of David' is designed to exhibit resistance to disease, insects, and dampness, along with improved cold tolerance, ensuring a longer flowering season throughout the year.

Another noteworthy invention by Snyder includes the N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas. This patent pertains to formulations containing these compounds and their applications as 5-lipoxygenase inhibiting agents, showcasing his contributions to the field of medicinal chemistry.

Career Highlights

David W. Snyder's career has been marked by his dedication to innovation and research. At Eli Lilly and Company, he has been instrumental in developing groundbreaking products that leverage his scientific knowledge and creativity. His work not only amplifies the company's portfolio but also advances the industry significantly.

Collaborations

Throughout his career, David has closely collaborated with colleagues such as Gary A. Hite and Edward David Mihelich. These partnerships have fostered a rich environment of innovation, enhancing the research and development process at their organization.

Conclusion

In conclusion, David W. Snyder stands out as a prominent figure in the landscape of modern inventors. His contributions through his patents are not just reflections of his talent, but they also highlight the importance of innovation in both horticulture and medicinal applications. His ongoing work with Eli Lilly and Company promises to further enrich the fields in which he operates.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…